All In MedTech

Device Trial Radar · NCT02401555

Performance Evaluation of the Bio-Rad Geenius HIV1/2 Supplemental Assay

Last checked: Nov 20, 2026Latest source record: Mar 28, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

419

Actual

Start

Apr 2013

Primary completion

Dec 2013

Study completion Dec 2013

Sponsor

Lead sponsor
Bio-Rad LaboratoriesNot on our public-company list
Sponsor type
Industry
First posted
Mar 30, 2015

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study was to evaluate the performance of the Bio-Rad Geenius HIV 1/2 Supplemental Assay, a single-use immunochromatographic assay for the confirmation and differentiation of individual antibodies to Human Immunodeficiency Virus Types 1 and 2 (HIV-1 and HIV-2) in fingerstick whole blood, venous whole blood, serum, or plasma samples (EDTA, heparin, and sodium citrate).

Conditions

  • HIV

Interventions

  • Geenius HIV1/2 Supplemental AssayDevice

    The purpose of this study is to evaluate the performance of the Bio-Rad Geenius HIV1/2 Supplemental Assay test in finger stick whole blood, venous whole blood, serum or plasma (EDTA, heparin, sodium citrate).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Diagnostic Result of Assay (Bio-Rad Geenius HIV 1/2 Supplemental Assay) From Accuracy AnalysisTime frame: Up to 9 months

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • HIV/AIDS Division, San Fransisco General Hospital

    San Francisco, California

  • Blood Systems Research Institute

    San Francisco, California

  • Center for Disease Control and Prevention

    Atlanta, Georgia

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.